XENETIC BIOSCIENCES, INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$8M
↑+21.2% +$1Mvs FY2024
Total Liabilities
$968K
↑+8.2% +$74Kvs FY2024
Equity
$7M
↑+23.1% +$1Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $8M | $7M |
| Current Assets | $8M | $7M |
| Cash | $0 | $0 |
| ST Investments | $0 | $0 |
| Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other Current | $8M | $7M |
| Non-Current Assets | $314K | $314K |
| PPE | $0 | $0 |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $314K | $314K |
| Total Liab+Eq | $8M | $7M |
| Current Liab. | $968K | $894K |
| Accounts Payable | $258K | $284K |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $710K | $611K |
| Non-Current Liab. | $0 | $0 |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $0 | $0 |
| Equity | $7M | $6M |
| Retained Earnings | $200M | $197M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · XBIO · Comparing FY2025 vs FY2024